Navigation Links
Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx
Date:9/18/2013

n addition, Amgen competes with other companies with respect to some of its marketed products as well as for the discovery and development of new products.  Amgen believes that some of its newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Amgen's products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with its products.  In addition, while Amgen routinely obtains patents for its products and technology, the protection offered by its patents and patent applications may be challenged, invalidated or circumvented by its competitors and there can be no guarantee of Amgen's ability to obtain or maintain patent protection for its products or product candidates.  Amgen cannot guarantee that it will be able to produce commercially successful products or maintain the commercial success of its existing products.  Amgen's stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of its products or product candidates.  Further, the discovery of significant problems with a product similar to one of Amgen's products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on Amgen's business and results of operations.

Additional Information
This communication is neither an offer to purchase nor a solicitation of an offer to sell any shares of the common stock of Onyx Pharmaceuticals, Inc. or any other securities.  Arena Acquisition Company and Amgen Inc. have filed a tender offer statement on Schedule TO, including an offer to purchase, a letter of transmittal and related documents, with the United States Securities and Exchange Commission (the "SEC") and a Solicitation/Recommendation Statement on Schedule 14D-9 has bee
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
2. Amgen To Participate At Citis 8th Annual Biotech Conference
3. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
4. Amgen to Highlight New Data at Upcoming ESC Congress 2013
5. Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders
6. Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
7. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
8. Amgens Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
9. Amgen Announces Webcast of 2013 Second Quarter Financial Results
10. Amgen Award For Science Teaching Excellence Honors Outstanding Teachers
11. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... commands the vital signs monitoring devices market with over ... . The North American and European vital signs monitors ... million, respectively, by the end of 2013. They have ... number of elderly people across these economies. The European ... owing to the rising demand for home health patient ...
(Date:9/2/2014)... NEW YORK , Sept. 2, 2014 /PRNewswire/ ... report is available in its catalogue: ... 2014 http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html ... H2, 2014 Summary GlobalData,s clinical ... Review, H2, 2014" provides data on the Acute ...
(Date:9/2/2014)...   Santa Clara dentist , Dr. Alan ... Invisalign. Invisalign is an orthodontic system that uses clear ... the orthodontic treatment of choice for older teens and ... For a limited time, patients can try Invisalign for ... usual cost. This offer cannot be combined, and some ...
Breaking Medicine Technology:Market of Vital Signs Monitoring Devices Forecast to 2018 2Market of Vital Signs Monitoring Devices Forecast to 2018 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2
... , HAMBURG , Feb. 3 ... Wound Therapy (NPWT) will assemble this week to develop a ... NPWT Expert Panel is drafting recommendations for a range of ... published clinical evidence.  Where published evidence is insufficient, the Panel ...
... Feb. 2 Celsis In Vitro, Inc. (Celsis IVT) ... XenoTech LLC, Sekisui Chemical Co. Ltd., and Sekisui Medical Co. Ltd. ... Illinois in Chicago .  XenoTech and Sekisui Medical ... processes and methods performed by XenoTech associated with its in ...
Cached Medicine Technology:International NPWT Expert Panel Convenes in Hamburg 2International NPWT Expert Panel Convenes in Hamburg 3Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui 2Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui 3
(Date:9/2/2014)... Los Angeles, CA (PRWEB) September 02, 2014 ... an article on its website titled “Why You Should ... more than 80 percent of the global population breathes ... droplets and particles of pollution lodge in the skin’s ... the body’s natural barrier to free radicals that may ...
(Date:9/2/2014)... women diagnosed with early-stage breast cancer in California, the ... and 2011, although this procedure was not associated with ... radiation, according to a study in the September 3 ... that surgery for the removal of one breast was ... other options examined in the study. , Randomized trials ...
(Date:9/2/2014)... within a few days of discharge do so principally because ... in other parts of the health care system, according to ... Annals of Emergency Medicine ( "Return Visits to the ... asked why they did not follow up as an outpatient, ... wait until their scheduled appointment or being instructed to return ...
(Date:9/2/2014)... Operators in the Community Services ... annually, arranging care and counsel for those in need. ... expected to derive $39.4 billion in revenue, which includes ... Over the five years through 2014-15, the subdivision is ... including growth of 4.1% in 2014-15. , As the ...
(Date:9/2/2014)... Steven Reinberg ... News) -- Stimulant medications -- such as Adderall, Ritalin ... in children, won,t stunt their growth, a new study ... height as adults," said study researcher Dr. Slavica Katusic, ... in Rochester, Minn. Katusic noted that results of ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 2Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 3
... first time, scientists report a link between eating nuts and ... metabolic syndrome (MetS), who are at high risk for heart ... and decreases feelings of hunger, makes people feel happier and ... nuts (raw unpeeled walnuts, almonds and hazelnuts) a day to ...
... University Medical Center and Nationwide Children,s Hospital have developed a ... of people born with an inherited, progressive form of blindness ... of a clinical trial investigating the use of gene therapy ... people worldwide. The trial is being conducted by researchers at ...
... (BMI)are important risk factors for gestational diabetes mellitus (GDM) particularly ... published today (02 November) in BJOG: An International Journal ... the link between maternal age, BMI and racial origin with ... other. Data were collected on 585,291 pregnancies in ...
... of Michigan Health System laboratory study reveals a key trigger ... a new treatment for those with sickle cell disease. ... early edition of the Proceedings of the National Academy ... episodes and organ damage that are common complications of sickle ...
... depends on diagnostic tests, diagnostic physicians have a responsibility ... or unexpected findings. According to an article selected as ... recent edition of the Journal of the American ... growth of diagnostic testing appears to be placing physicians ...
... News) -- A new surgical method that uses a natural ... less scarring and faster recovery for patients, according to the ... used in this type of procedure is located behind the ... surgeries to remove skull base tumors require incisions through the ...
Cached Medicine News:Health News:Benefits of nut consumption for people with abdominal obesity, high blood sugar, high blood pressure 2Health News:Ohio State researchers design a viral vector to treat a genetic form of blindness 2Health News:Age and BMI can predict likelihood of developing gestational diabetes new research suggests 2Health News:Age and BMI can predict likelihood of developing gestational diabetes new research suggests 3Health News:Researchers reveal potential treatment for sickle cell disease 2Health News:Diagnostic physicians at increased risk for medical malpractice claims due to communication failures 2Health News:New Technique to Remove Skull Tumors May Mean Less Scarring 2
... Designed for the Anterior Segment The ... lens practitioners and ophthalmologists specializing in the anterior ... emergency rooms. Video- c-mount camera on the BD ... port. Standard magnification in 10 and 16 X ...
... FVL is a new functional test which ... Activated Protein C Resistance caused by the ... to other commercially available methods, Pefakit APC-R ... or S, Lupus Anticoagulants, Elevated FVIII levels, ...
... Used for venous pressure monitoring, blood ... fluids. Turbo-Flo polyurethane PICC line sets ... Rates, Micropuncture Introducer Needle, ... be trimmed to patient specific anatomy. ...
Assess serum Gc-globulin levels in patients with multiple trauma, fulminant liver failure, acetaminophen overdose, and sepsis....
Medicine Products: